about
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune,...
Read More
2.78
-0.08
(-2.80%)
1.6M
XNAS Volume
XNAS 24 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for INmune Bio Inc is on 01 Aug 2025 for the purpose of INmune Bio Inc Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
INmune Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..